Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Short Interest Update

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) was the recipient of a large increase in short interest in February. As of February 13th, there was short interest totaling 28,112 shares, an increase of 36.0% from the January 29th total of 20,671 shares. Based on an average daily trading volume, of 175,300 shares, the short-interest ratio is currently 0.2 days. Approximately 0.0% of the company’s stock are sold short. Approximately 0.0% of the company’s stock are sold short. Based on an average daily trading volume, of 175,300 shares, the short-interest ratio is currently 0.2 days.

Xtant Medical Stock Up 0.2%

Shares of NYSEAMERICAN XTNT traded up $0.00 during trading hours on Monday, hitting $0.57. 90,678 shares of the stock were exchanged, compared to its average volume of 160,222. Xtant Medical has a 12 month low of $0.34 and a 12 month high of $0.95. The firm has a fifty day moving average price of $0.66 and a 200-day moving average price of $0.68. The company has a quick ratio of 1.06, a current ratio of 2.21 and a debt-to-equity ratio of 0.35. The company has a market cap of $80.00 million, a PE ratio of 57.20 and a beta of -0.30.

Analyst Upgrades and Downgrades

Separately, BTIG Research decreased their price target on shares of Xtant Medical from $2.00 to $1.50 and set a “buy” rating for the company in a research note on Tuesday, November 11th. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat, Xtant Medical presently has an average rating of “Buy” and an average target price of $1.50.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Jane Street Group LLC purchased a new stake in Xtant Medical in the second quarter valued at about $26,000. Tradition Wealth Management LLC acquired a new position in shares of Xtant Medical during the fourth quarter valued at about $79,000. Wiregrass Investment Management LLC purchased a new position in shares of Xtant Medical in the 4th quarter valued at approximately $81,000. Mink Brook Asset Management LLC boosted its stake in Xtant Medical by 125.8% in the 2nd quarter. Mink Brook Asset Management LLC now owns 109,466 shares of the medical device company’s stock worth $81,000 after purchasing an additional 60,997 shares in the last quarter. Finally, Nano Cap New Millennium Growth Fund L P purchased a new stake in Xtant Medical during the 4th quarter worth approximately $220,000. 69.33% of the stock is currently owned by hedge funds and other institutional investors.

Xtant Medical Company Profile

Xtant Medical, Inc is a medical technology company focused on the development, manufacturing and distribution of bone graft, spine biologics and related implantable medical devices. The company’s product portfolio is designed to address critical needs in spinal fusion, orthopedics and trauma surgery by providing a range of solutions that promote bone growth, structural support and patient recovery.

The company’s offerings include an array of bone graft substitutes – such as demineralized bone matrix putties and fibers – interbody fusion devices, spinal fixation systems and biologic agents.